KNOTT DAVID M - BIOCRYST PHARMACEUTICALS INC ownership

BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 172 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
KNOTT DAVID M ownership history of BIOCRYST PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$312,000
-80.9%
30,703
-86.0%
0.13%
-82.0%
Q4 2020$1,635,000
+19.8%
219,461
-44.8%
0.74%
-7.6%
Q3 2020$1,365,000
-27.9%
397,3610.0%0.80%
-22.5%
Q2 2020$1,893,000
+1477.5%
397,361
+562.4%
1.03%
+1259.2%
Q1 2020$120,00059,9900.08%
Other shareholders
BIOCRYST PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Burrage Capital Management LLC 1,105,673$8,237,0006.28%
Sarissa Capital Management LP 8,175,000$60,903,0006.22%
ORACLE INVESTMENT MANAGEMENT INC 2,980,870$22,207,0002.78%
DG Capital Management, LLC 1,075,732$8,014,0001.70%
Ghost Tree Capital, LLC 900,000$6,705,0001.49%
Parkman Healthcare Partners LLC 538,370$4,011,0001.03%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,835,810$43,477,0000.86%
Formidable Asset Management, LLC 470,419$3,470,0000.80%
KNOTT DAVID M 219,461$1,635,0000.74%
Altium Capital Management LP 250,000$1,863,0000.70%
View complete list of BIOCRYST PHARMACEUTICALS INC shareholders